chia sẻ:

Share on facebook
Share on twitter
Share on linkedin

Haliphar – Expanding Horizons with Reproductive Support Products at the 2nd Annual Fetal Medicine Conference

The Haliphar booth attracted a significant number of leading obstetricians and pediatricians with high-quality products from major global pharmaceutical companies.

The 2nd Annual Fetal Medicine Conference, organized by the National Hospital of Obstetrics and Gynecology, commenced with the theme “Neurological Congenital Anomalies: From Diagnosis to Intervention.” This conference, held on May 30-31, hosted 500 delegates, including leading experts from France, Hong Kong, Israel, and Vietnam, participating in person. Additionally, the conference connected Hanoi with 1,000 online participants.

In his opening remarks, Prof. Dr. Nguyen Duy Anh, Director of the National Hospital of Obstetrics and Gynecology, emphasized, “Fetal medicine is a rapidly evolving field globally, providing opportunities for the detection of congenital anomalies, addressing abnormal complications, and offering the best care and survival chances for fetuses in utero.”

Fetal medicine is a rapidly evolving field globally, providing opportunities for detecting congenital anomalies, addressing abnormal complications, and offering the best care and survival chances for fetuses in utero. As a leading pharmaceutical company, Haliphar continuously researches and collaborates to bring high-quality products from reputable pharmaceutical companies in Switzerland, Germany, Finland, and others. The products distributed by Haliphar are trusted and utilized by physicians and specialists at major hospitals such as Bach Mai, Viet Duc, National Hospital of Obstetrics and Gynecology, Hanoi Obstetrics and Gynecology Hospital, and Vinmec for patient treatment.

Participating in this conference provided Haliphar with the opportunity to update their expertise on fetal screening, diagnosis, and intervention methods from specialists and medical professionals across various fields, including obstetrics, neonatology, genetics, and pediatric surgery. This foundation will enable Haliphar to continue researching, strategizing, and establishing connections to bring more high-quality global products to Vietnam.